Vincerx Pharma, Inc. (VINC)
OTCMKTS · Delayed Price · Currency is USD
0.0495
+0.0043 (9.58%)
At close: Jul 21, 2025
Vincerx Pharma Market Cap
Vincerx Pharma has a market cap or net worth of $259.25 thousand as of July 22, 2025. Its market cap has decreased by -98.84% in one year.
Market Cap
259.25K
Enterprise Value
-4.18M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since May 27, 2020, Vincerx Pharma's market cap has decreased from 22.32M to 259.25K, a decrease of -98.84%. That is a compound annual growth rate of -57.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2025 | 259.25K | -97.07% |
| Dec 31, 2024 | 8.84M | -64.95% |
| Dec 29, 2023 | 25.23M | 16.73% |
| Dec 30, 2022 | 21.61M | -89.91% |
| Dec 31, 2021 | 214.20M | -26.75% |
| Dec 31, 2020 | 292.41M | 1,210.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.66B |
| Veradigm | 781.22M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 568.58M |
| Glass House Brands | 449.22M |
| CytoDyn | 394.89M |
| Northwest Biotherapeutics | 364.65M |